Transforming growth factor β in prostate cancer: Cellular effects and basic molecular mechanisms;"transforming growth factor β" im Prostatakarzinom: Zelluläre Wirkungen und molekulare Grundlagen

Urologe - Ausgabe A

Volumn 52, Issue 3, 2013, Pages 378-383

  Stope, M B ^a   Ronnau C ^a   Schubert, T ^a   Staar, D ^a   Bradl, J ^a   Ziegler, P ^b   Streitborger A ^a   Kroeger, N ^a   Zimmermann, U ^a   Walther, R ^a   Burchardt, M ^a   Borgermann C ^c  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c Krankenhaus Duren gem GmbH   (Germany)

Author keywords

Pro oncogenic effect; Progression; Proliferation signal transduction pathways; Signal transduction

Indexed keywords

ANDROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; HUMAN; MOLECULAR PATHOLOGY; PHENOTYPE; PROSTATE CANCER; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; HUMANS; MALE; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84878179644     PISSN: 03402592     EISSN: 14330563     Source Type: Journal    
DOI: 10.1007/s00120-012-3049-5     Document Type: Article

References (36)

1. Ahamed J, Burg N, Yoshinaga K et al (2008) In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-1. Blood 112:3650-3660
2. Ajiboye S, Sissung TM, Sharifi N et al (2010) More than an accessory: implications of type III transforming growth factor- receptor loss in prostate cancer. BJU Int 105:913-916
3. Arjaans M, Oude Munnink TH, Timmer-Bosscha H et al (2012) Transforming growth factor (TGF)- expression and activation mechanisms as potential targets for anti-tumor therapy and tumor imaging. Pharmacol Ther 135:123-132
4. Bruckheimer EM, Kyprianou N (2001) Dihydrotestosterone enhances transforming growth factor-induced apoptosis in hormone-sensitive prostate cancer cells. Endocrinol 142:2419-2426 (Pubitemid 32473098)
5. Danielpour D (2005) Functions and regulation of transforming growth factor-beta (TGF-) in the prostate. Eur J Cancer 41:846-857 (Pubitemid 40461689)
6. Di K, Ling MT, Tsao SW et al (2006) Id-1 modulates senescence and TGF-1 sensitivity in prostate epithelial cells. Biol Cell 98:523-533 (Pubitemid 44383369)
7. Di K, Wong YC, Wang X (2007) Id-1 promotes TGF-beta1-induced cell motility through HSP27 activation and disassembly of adherens junction in prostate epithelial cells. Exp Cell Res 313:3983-3999 (Pubitemid 47632543)
8. Diener KR, Need NF, Buchanan G et al (2010) TGF-beta signalling and immunity in prostate tumourigenesis. Expert Opin Ther Targets 14:179-192
9. Edlund S, Bu S, Schuster N et al (2003) Transforming growth factor-1 (TGF-)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell 14:529-544 (Pubitemid 36237014)
10. Festuccia C, Bologna M, Gravina GL et al (1999) Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components. Int J Cancer 81:395-403 (Pubitemid 29165198)
11. Huang X, Chen S, Xu L et al (2005) Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res 65:3470-3478 (Pubitemid 40524634)
12. Joffroy CM, Buck MB, Stope MB et al (2010) Antiestrogens induce transforming growth factor α-mediated immunosuppression in breast cancer. Cancer Res 70:1314-1322
13. Kang HY, Huang KE, Chang SY et al (2002) Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J Biol Chem 277:43749-43756 (Pubitemid 36157793)
14. Konrad L, Schreiber JA, Schwarz L et al (2009) TGF-1 and TGF-2 strongly enhance the secretion of plasminogen activator inhibitor-1 and matrix metalloproteinase-9 of the human prostate cancer cell line PC-3. Regul Pept 155:28-32
15. Lamm MLG, Long DD, Goodwin SM et al (1997) Transforming growth factor-1 inhibits membrane association of protein kinase C in a human prostate cancer cell line, PC3. Endocrinol 138:4657-4664 (Pubitemid 27460900)
16. Le Brun G, Aubin P, Soliman H et al (1998) Upregulation of endothelin 1 and its precursor by IL-1, TNF-, and TGF- in the PC3 human prostate cancer cell line. Cytokine 11:157-162
17. Lecanda J, Parekh TV, Gama P et al (2007) Transforming growth factor-, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium. Cancer Res 67:1007-1018
18. Li X, Placencio V, Iturregui JM et al (2008) Prostate tumor progression is mediated by a paracrine TGF-/Wnt3a signaling axis. Oncogene 27:7118-7130
19. Lu S, Dong Z. (2006) Characterization of TGF-regulated interleukin-8 expression in human prostate cancer cells. Prostate 66:996-1004 (Pubitemid 43849597)
20. Massague J, Seoane J, Wotton D. (2005) Smad transcription factors. Genes Dev 19:2783-2810 (Pubitemid 41739965)
21. Noda D, Itoh S, Watanabe Y et al (2006) ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-/Smad-induced growth arrest of prostate cells. Oncogene 25:5591-5500
22. Park B-J, Park J-I, Byun D-S et al (2000) Mitogenic conversion of transforming growth factor-1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer. Cancer Res 60:3031-3038 (Pubitemid 30395831)
23. Park J-I, Lee M-G, Cho K et al (2003) Transforming growth factor-1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene 22:4314-4332 (Pubitemid 36897963)
24. Perry KT, Anthony CT, Steiner MS (1997) Immunohistochemical localization of TGF 1, TGF 2, and TGF 3 in normal and malignant human prostate. Prostate 33:133-140 (Pubitemid 27415537)
25. Reis ST, Pontes-Junior J, Antunes AA et al (2011) Tgf-1 expression as a biomarker of poor prognosis in prostate cancer. Clinics 66:1143-1147
26. Sakko AJ, Ricciardelli C, Mayne K et al (2001) Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1. Cancer Res 61:926-930 (Pubitemid 32174405)
27. Sehgal I, Thompson TC (1999) Novel regulation of type IV collagenase (matrix metalloproteinase-9 and 2) activities by transforming growth factor- 1 in human prostate cancer cell lines. Mol Biol Cell 10:407-416 (Pubitemid 29156481)
28. Sintich SM, Lamm MLG, Sensibar JA et al (1999) Transforming growth factor-1-induced proliferation of the prostate cancer cell line, TSU-Pr1: The role of platelet-derived growth factor. Endocrinol 140:3411-3415 (Pubitemid 30645395)
29. Steiner MS, Wand GS, Barrack ER (1994) Effects of transforming growth factor 1 on the adenylyl cyclase-cAMP pathway in prostate cancer. Growth Factors 11:283-290
30. Stope MB, Popp SL, Knabbe C et al (2010) Estrogen receptor alpha attenuates transforming growth factor- signaling in breast cancer cells independent from agonistic and antagonistic ligands. Breast Cancer Res Treat 120:357-367
31. Stope MB, Schubert T, Staar D et al (2012) Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells. World J Urol 30:327-331
32. Unlü A, Leake RE (2003) Transforming growth factor 1 stimulates urokinase plasminogen activator system on prostate cancer cells. Int J Biol Markers 18:147-151 (Pubitemid 38220143)
33. Weydert CJ, Esser AK, Mejia RA et al (2009) Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arterioles. Cancer Biol Ther 8:720-729
34. Xu L, Chen S, Bergan RC (2006) MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Oncogene 25:2987-2998 (Pubitemid 43780463)
35. Yang F, Strand DW, Rowley DR (2008) Fibroblast growth factor-2 mediates transforming growth factor- action in prostate cancer reactive stroma. Oncogene 27:450-459
36. Zhu B, Fukada K, Zhu H et al (2006) Prohibitin and cofilin are intracellular effectors of transforming growth factor signaling in human prostate cancer cells. Cancer Res 66:8640-8647 (Pubitemid 44449179)